Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia [Phase 2]
Phase II open-label study of high-dose cytarabine combined with clofarabine in adults with refractory or relapsed acute myeloid leukemia or …
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: XK469R in Treating Patients With Refractory Hematologic Cancer [Phase 1]
Phase 1 trial update reporting initial safety and tolerability findings for XK469R in patients with refractory hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia [Phase 1]
NCI-sponsored Phase 1 clinical trial update of 6-Hydroxymethylacylfulvene (Irofulven) in patients with refractory acute myeloid leukemia, ac…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Retrospective Evaluation of the Clinical Results Obtained in Patients With Acute Lymphoblastic Leukemia Treated at the San Giovanni Battista Hospital.
This report provides retrospective clinical results from patients with acute lymphoblastic leukemia treated at San Giovanni Battista Hospita…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]
Phase 2 clinical trial update for 506U78 in patients with refractory or relapsed acute lymphoblastic leukemia or lymphoblastic lymphoma (NCI…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate [Phase 1]
Phase 1 clinical trial update of dasatinib in pediatric patients with Philadelphia chromosome–positive leukemia or recurrent/refractory soli…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia [Phase 4]
Phase 4 multi-center trial ALL-REZ BFM 2002 for children with relapsed acute lymphoblastic leukemia has completed enrollment and status is c…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 clinical trial evaluated radiation therapy combined with chemotherapy for children with CNS relapse of acute lymphoblastic leukemi…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 study of augmerosen with fludarabine and cytarabine in patients with refractory or relapsed acute myeloid leukemia or acute lymphobl…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia [NA]
A completed clinical trial evaluated a vaccine therapy to prevent influenza in children with acute lymphoblastic leukemia.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies [Phase 1]
Phase 1 trial evaluating the combination of triapine (3-AP) with high-dose cytarabine in adults with advanced hematologic malignancies has c…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial update (completed) of PS-341 (bortezomib) in patients with refractory or relapsed acute myeloid leukemia, acute lymph…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 study evaluating a rebeccamycin analog in adults with relapsed or refractory acute myeloid leukemia, myelodysplastic syndromes, acut…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase [Phase 2]
A Phase 2 trial evaluating CCI-779 (temsirolimus) in adults with relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia [Phase 1]
Phase 1 study of BMS-214662 in patients with various leukemias and myelodysplastic syndromes has completed enrollment; the document lists th…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1]
A Phase 1 pediatric trial evaluates decitabine for relapsed or refractory acute myeloid leukemia and acute lymphoblastic leukemia, including…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Raltitrexed in Treating Children With Refractory Acute Leukemia [Phase 1]
This document provides an update on a Phase 1 clinical trial of Raltitrexed for refractory acute leukemia in children, including recurrent c…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [NA]
Completed clinical trial evaluating a combination chemotherapy regimen for newly diagnosed pediatric acute lymphoblastic leukemia, including…
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes [Phase 1]
This Phase 1 trial evaluated SB-715992 in adults with various acute leukemias, chronic myeloid leukemia in blast phase, and advanced myelody…
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: Pharmacokinetic Profile of Vincristine Administered With Imatinib for Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) Compared to That Without Imatinib for Bcr-Abl Negative ALL
A terminated clinical trial comparing the pharmacokinetic profile of vincristine when given with imatinib in BCR-ABL positive acute lymphobl…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
A Phase 1 trial evaluating sorafenib in adults with relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia, or chronic …
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 clinical trial evaluating dasatinib in patients with chronic myeloid leukemia or acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases [Phase 1]
This Phase 1 trial evaluates the safety and feasibility of combining vorinostat with decitabine in adults with relapsed, refractory, or poor…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission [Phase 2]
Phase 2 study of reduced-intensity conditioning followed by donor stem cell transplant for high-risk acute lymphoblastic leukemia in complet…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor [Phase 2]
Phase 2 study evaluating parathyroid hormone after sequential cord blood transplantation from an unrelated donor; the trial was terminated a…